학술논문

Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
Document Type
Review
Source
In: Advances in Therapy. (Advances in Therapy, May 2021, 38(5):2038-2053)
Subject
Language
English
ISSN
18658652
0741238X